Cargando…

Potential therapeutic effect of targeting glycogen synthase kinase 3β in esophageal squamous cell carcinoma

Esophageal squamous cell carcinoma (ESCC) is a common gastrointestinal cancer and is often refractory to current therapies. Development of efficient therapeutic strategies against ESCC presents a major challenge. Glycogen synthase kinase (GSK)3β has emerged as a multipotent therapeutic target in var...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bolidong, Dilireba, Domoto, Takahiro, Uehara, Masahiro, Sabit, Hemragul, Okumura, Tomoyuki, Endo, Yoshio, Nakada, Mitsutoshi, Ninomiya, Itasu, Miyashita, Tomoharu, Wong, Richard W., Minamoto, Toshinari
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7367341/ https://www.ncbi.nlm.nih.gov/pubmed/32678196 http://dx.doi.org/10.1038/s41598-020-68713-9

Ejemplares similares

Glycogen Synthase Kinase 3β in Cancer Biology and Treatment
por: Domoto, Takahiro, et al.
Publicado: (2020)

Glycogen synthase kinase‐3β participates in acquired resistance to gemcitabine in pancreatic cancer
por: Uehara, Masahiro, et al.
Publicado: (2020)

Glycogen synthase kinase‐3β is a pivotal mediator of cancer invasion and resistance to therapy
por: Domoto, Takahiro, et al.
Publicado: (2016)

Biological basis and clinical study of glycogen synthase kinase- 3β-targeted therapy by drug repositioning for glioblastoma
por: Furuta, Takuya, et al.
Publicado: (2017)

Glycogen synthase kinase 3β as a potential therapeutic target in synovial sarcoma and fibrosarcoma
por: Abe, Kensaku, et al.
Publicado: (2019)

Identification of GSK3β inhibitor kenpaullone as a temozolomide enhancer against glioblastoma
por: Kitabayashi, Tomohiro, et al.
Publicado: (2019)

Aberrant Glycogen Synthase Kinase 3β Is Involved in Pancreatic Cancer Cell Invasion and Resistance to Therapy
por: Kitano, Ayako, et al.
Publicado: (2013)

Colorectal cancer cells require glycogen synthase kinase-3β for sustaining mitosis via translocated promoter region (TPR)-dynein interaction
por: Dewi, Firli R.P., et al.
Publicado: (2018)

Aberrant glycogen synthase kinase 3β in the development of pancreatic cancer
por: Shimasaki, Takeo, et al.
Publicado: (2012)

Volumetric growth analysis of an insular dysembryoplastic neuroepithelial tumor over a 10-year follow-up
por: Uno, Takehiro, et al.
Publicado: (2016)

Efficacy of glycogen synthase kinase-3β targeting against osteosarcoma via activation of β-catenin
por: Shimozaki, Shingo, et al.
Publicado: (2016)

RBPJ contributes to the malignancy of glioblastoma and induction of proneural‐mesenchymal transition via IL‐6‐STAT3 pathway
por: Zhang, Guangtao, et al.
Publicado: (2020)

Tumor Microenvironment in Glioma Invasion
por: Tamai, Sho, et al.
Publicado: (2022)

The strategy for enhancing temozolomide against malignant glioma
por: Nakada, Mitsutoshi, et al.
Publicado: (2012)

CBMS-12 PENTAMIDINE; TRANSLATIONAL RESEARCH FOR A NEW CHEMOTHERAPY TARGETING ON GLIOMA CELLS AND GLIOMA STEM CELLS USING DRUG REPOSITIONING
por: Tamai, Sho, et al.
Publicado: (2019)

Therapeutic potential of pentamidine for glioma‐initiating cells and glioma cells through multimodal antitumor effects
por: Tamai, Sho, et al.
Publicado: (2023)

Dynamic switch of immunity and antitumor effects of metformin in rat spontaneous esophageal carcinogenesis
por: Takei, Ryohei, et al.
Publicado: (2021)

Correction to: Dynamic switch of immunity and antitumor effects of metformin in rat spontaneous esophageal carcinogenesis
por: Takei, Ryohei, et al.
Publicado: (2021)

Establishment of Anti-Human ATRX Monoclonal Antibody AMab-6
por: Ogasawara, Satoshi, et al.
Publicado: (2016)

Nucleoporin TPR (translocated promoter region, nuclear basket protein) upregulation alters MTOR-HSF1 trails and suppresses autophagy induction in ependymoma
por: Dewi, Firli Rahmah Primula, et al.
Publicado: (2020)

Glycogen Synthase Kinase-3
por: Crouch, Peter, et al.
Publicado: (2011)

Control of Glycogen Content in Retina: Allosteric Regulation of Glycogen Synthase
por: Osorio-Paz, Ixchel, et al.
Publicado: (2012)

Identification of blood biomarkers in glioblastoma by SWATH mass spectrometry and quantitative targeted absolute proteomics
por: Miyauchi, Eisuke, et al.
Publicado: (2018)

Gelsolin inhibits malignant phenotype of glioblastoma and is regulated by miR‐654‐5p and miR‐450b‐5p
por: Zhang, Jiakang, et al.
Publicado: (2020)

Identification of antipsychotic drug fluspirilene as a potential anti-glioma stem cell drug
por: Dong, Yu, et al.
Publicado: (2017)

Establishing a xenograft mouse model of peritoneal dissemination of gastric cancer with organ invasion and fibrosis
por: Okazaki, Mitsuyoshi, et al.
Publicado: (2017)

The effect of HIF-1α and PKM1 expression on acquisition of chemoresistance
por: Okazaki, Mitsuyoshi, et al.
Publicado: (2018)

Incidence of and risk factors for totally implantable vascular access device complications in patients with gastric cancer: A retrospective analysis
por: Okazaki, Mitsuyoshi, et al.
Publicado: (2019)

Mechanism of glycogen synthase inactivation and interaction with glycogenin
por: Marr, Laura, et al.
Publicado: (2022)

Interactomes of Glycogen Synthase Kinase-3 Isoforms
por: Cormier, Kevin W., et al.
Publicado: (2023)

Thymidylate synthase locus LOH in combination with genotype has prognostic and predictive significance in colorectal cancer
por: Kotake, Masanori, et al.
Publicado: (2021)

Valproic acid inhibits irradiation-induced epithelial-mesenchymal transition and stem cell-like characteristics in esophageal squamous cell carcinoma
por: Kanamoto, Ayako, et al.
Publicado: (2016)

Hexokinase 2, Glycogen Synthase and Phosphorylase Play a Key Role in Muscle Glycogen Supercompensation
por: Irimia, José M., et al.
Publicado: (2012)

Low-dose eribulin mesylate exerts antitumor effects in gastric cancer by inhibiting fibrosis via the suppression of epithelial–mesenchymal transition and acts synergistically with 5-fluorouracil
por: Kurata, Toru, et al.
Publicado: (2018)

Potential of extravasated platelet aggregation as a surrogate marker for overall survival in patients with advanced gastric cancer treated with preoperative docetaxel, cisplatin and S-1: a retrospective observational study
por: Saito, Hiroto, et al.
Publicado: (2017)

Glycogen synthase kinase 3β in tumorigenesis and oncotherapy
por: He, Rui, et al.
Publicado: (2020)

Glycogen synthase kinase 3 promotes multicellular development over unicellular encystation in encysting Dictyostelia
por: Kawabe, Yoshinori, et al.
Publicado: (2018)

Inhibition of Glycogen Synthase II with RNAi Prevents Liver Injury in Mouse Models of Glycogen Storage Diseases
por: Pursell, Natalie, et al.
Publicado: (2018)

Glycogen Synthase Kinase-3 in the Etiology and Treatment of Mood Disorders
por: Jope, Richard Scott
Publicado: (2011)

Glycogen Synthase Kinase-3 is an Intermediate Modulator of Serotonin Neurotransmission
por: Polter, Abigail M., et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_8i84fvl3qji1r2fngue3g2ouk8